亚太地区关节疼痛注射市场预测至 2028 年 - COVID-19 影响和药物（透明质酸、皮质类固醇等）、关节类型（膝、足和踝、肩和肘、髋等）和分布的区域分析渠道（零售药店、医院药店等）
No. of Pages: 134 | Report Code: TIPRE00024539 | Category: Life Sciences
No. of Pages: 134 | Report Code: TIPRE00024539 | Category: Life Sciences
亚太地区关节止痛注射 市场是
亚太地区多个国家见证了前所未有的治疗效果。 COVID-19 病例数量增加，导致包括关节痛注射剂在内的多种医疗保健产品的多项业务运营和生产活动停止，这对 2020 年初的关节痛注射剂市场产生了负面影响。员工隔离，供应链故障和需求减少给企业带来了严重的麻烦。此外，私立连锁医院的住院和门诊人数也大幅下降。为了缓解医疗系统的压力，许多诊所已经推迟了非关键手术。为了避免医院负担过重，医院已经在努力应对不断上升的流行病压力，医生们将手术推迟到 Covid-19 高峰过去。此外，医疗器械公司开始预测，由于人们呆在家里，中国市场的销售额将大幅下降。许多大型医疗器械公司，如 Stryker、CartiHeal Inc. 和 Smith & Nephew预测中国销量将下降。中国大陆、香港和台湾的医院一直在推迟骨科手术，以防止病毒在该地区传播。 2月份中国几乎没有进行择期手术。预计到 2028 年，择期手术数量的下降将阻碍亚太地区关节疼痛注射市场的发展。
亚太地区关节疼痛注射剂市场预计将从2021年的4.0196亿美元增长到2028年的6.759亿美元；预计 2021 年至 2028 年复合年增长率为 7.7%。多年来，该地区的医疗保健行业经历了快速转型。此外，推动医疗保健行业增长的因素包括骨科疾病患病率上升、人口老龄化、收入和负担能力增加，导致医疗服务的需求和利用增加。由于医疗旅游业的兴起需要先进的医疗技术，以及对骨科治疗的需求持续增长，亚太地区拥有各种增长机会。此外，各个国际市场参与者正在将其制造工厂转移到印度，预计这将在预测期内显着推动市场增长。
从药品来看，2020年亚太关节止痛注射液市场中，透明质酸细分市场占据最大份额。从关节类型来看，膝关节细分市场占据了最大份额。 2020年亚太关节止痛注射剂市场份额最大。从分销渠道来看，医院药房业务占据2020年亚太关节止痛注射剂市场最大份额。
准备本亚太关节止痛注射报告时参考的一些主要一手和二手来源市场包括公司网站、年报、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括中外制药株式会社；生物文图斯公司； Fidia Pharma 美国公司；生化学株式会社；辉凌有限公司；赛诺菲； Anika Therapeutics, Inc. 和 Teva Pharmaceutical Industries Ltd.。
Strategic insights for Asia Pacific Joint Pain Injection involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 401.96 Million |
| Market Size by 2028 | US$ 675.90 Million |
| Global CAGR (2021 - 2028) | 7.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Joint Pain Injection refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Joint Pain Injection Market is valued at US$ 401.96 Million in 2021, it is projected to reach US$ 675.90 Million by 2028.
As per our report Asia Pacific Joint Pain Injection Market, the market size is valued at US$ 401.96 Million in 2021, projecting it to reach US$ 675.90 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.
The Asia Pacific Joint Pain Injection Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Joint Pain Injection Market report:
The Asia Pacific Joint Pain Injection Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Joint Pain Injection Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Joint Pain Injection Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Joint Pain Injection Market
